These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479 [TBL] [Abstract][Full Text] [Related]
4. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Morgan MJ; McFie L; Fleetwood H; Robinson JA Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362 [TBL] [Abstract][Full Text] [Related]
5. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. Reay JL; Hamilton C; Kennedy DO; Scholey AB J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712 [TBL] [Abstract][Full Text] [Related]
6. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713 [TBL] [Abstract][Full Text] [Related]
12. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users. Parrott AC Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456 [TBL] [Abstract][Full Text] [Related]
13. The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. McCann UD; Peterson SC; Ricaurte GA Neuropsychopharmacology; 2007 Aug; 32(8):1695-706. PubMed ID: 17203011 [TBL] [Abstract][Full Text] [Related]
14. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Curran HV; Verheyden SL Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801 [TBL] [Abstract][Full Text] [Related]
15. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910 [TBL] [Abstract][Full Text] [Related]
16. Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users. Blagrove M; Seddon J; George S; Parrott AC; Stickgold R; Walker MP; Jones KA; Morgan MJ J Psychopharmacol; 2011 Apr; 25(4):465-77. PubMed ID: 20615932 [TBL] [Abstract][Full Text] [Related]
17. Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users. Zakzanis KK; Young DA; Radkhoshnoud NF Appl Neuropsychol; 2002; 9(2):84-91. PubMed ID: 12214826 [TBL] [Abstract][Full Text] [Related]
18. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users. Burgess AP; Venables L; Jones H; Edwards R; Parrott AC Psychopharmacology (Berl); 2011 Aug; 216(4):545-56. PubMed ID: 21390504 [TBL] [Abstract][Full Text] [Related]
19. Executive function in abstinent MDMA ('ecstasy') users. Zakzanis KK; Young DA Med Sci Monit; 2001; 7(6):1292-8. PubMed ID: 11687745 [TBL] [Abstract][Full Text] [Related]
20. Patterns of memory dysfunction in current and 2-year abstinent MDMA users. Ward J; Hall K; Haslam C J Clin Exp Neuropsychol; 2006 Apr; 28(3):306-24. PubMed ID: 16618622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]